| Rajesh Sonani, MD | |
|
10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 | |
| (702) 800-5393 | |
| (702) 407-7016 |
| Full Name | Rajesh Sonani |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 10624 S Eastern Ave # A-955, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366899585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | TRN23397 (Florida) | Secondary |
| 207R00000X | Internal Medicine | 18534 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mountainview Hospital | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pioneer Health Care Llc | 3577560457 | 28 |
| Clinicians Medical Group Llc | 6204099211 | 8 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
| Entity Name | Valley Primary Care Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568659381 PECOS PAC ID: 1254392806 Enrollment ID: O20041026000891 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
| Entity Name | Pioneer Health Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588681332 PECOS PAC ID: 3577560457 Enrollment ID: O20061107000417 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
| Entity Name | Platinum Hospitalists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861627242 PECOS PAC ID: 7214076322 Enrollment ID: O20091203000160 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
| Entity Name | Clinicians Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770843328 PECOS PAC ID: 6204099211 Enrollment ID: O20120531000112 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
| Entity Name | Tudor C Jianu Md A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508368317 PECOS PAC ID: 9638432966 Enrollment ID: O20180418002048 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
| Entity Name | Healthnomic Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740850106 PECOS PAC ID: 7315342094 Enrollment ID: O20210818001437 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rajesh Sonani, MD 10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 Ph: (702) 800-5393 | Rajesh Sonani, MD 10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 Ph: (702) 800-5393 |
News Archive
A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.
Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.
America's workers suffer more workplace injury and illness than employers report, and medical professionals are under pressure from employers to misdiagnose and under-treat work-related health conditions, according to a new report from the Government Accountability Office (GAO).
› Verified 7 days ago
James B Gabroy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1535 West Warm Spring Road, Suite 135, Henderson, NV 89014 Phone: 702-450-3385 Fax: 702-898-1699 | |
Dr. Poupak Ziaei, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2641 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-616-0091 Fax: 702-616-2329 | |
Dr. Jeannette Nee, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2865 Siena Heights Dr, Suite 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Wen Liang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2621 W Horizon Ridge Pkwy, Suite 150, Henderson, NV 89052 Phone: 702-837-6368 Fax: 702-837-0685 | |
Randy James Ip, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Linda Lou Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 W Sunset Rd, Henderson, NV 89014 Phone: 725-269-7001 Fax: 725-269-7003 | |
Dr. Daejoon Anh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 |